Cardiogenic Shock Post Myocardial Infarction: Clinical Trials

10 trials for Cardiogenic Shock Post Myocardial Infarction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 recruiting, 2 not yet recruiting, 1 enrolling by invitation, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 11Not yet recruiting 1
Phase 31Recruiting 1

Follow Cardiogenic Shock Post Myocardial Infarction: new trials by email Literature Review of Cardiogenic Shock Post Myocardial Infarction trials Research Report on Cardiogenic Shock Post Myocardial Infarction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hong Kong Cardiogenic Shock Initiative
Cardiogenic Shock Acute, STEMI - ST Elevation Myocardial Infarction
Not yet recruitingPrince of Wales Hospital, Shatin, Hong Kong3202026-12-012026-09-16
Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK)
Cardiogenic Shock Acute, Cardiogenic Shock
RecruitingHospital de Santa Cruz, Portugal8002026-06-102026-06-11
OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science
Micro-axial flow pump support - Cardiogenic Shock, Mechanical Circulatory Support
RecruitingMedical University of Vienna1002026-05-082026-06-01
Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support
Escalation to more capable microaxial flow-pump (Impella 5.5) - Cardiogenic Shock Post Myocardial Infarction
RecruitingUniversity Hospital of Cologne1152026-04-232026-08-27
Ivabradine in the Acute Management of Cardiogenic Shock
Ivabradine 5mg Tab, Placebo Oral Tablet - Cardiogenic Shock Post Myocardial Infarction
Phase 3RecruitingNational Institute of Cardiovascular Diseases, Pakistan2002026-04-202026-07-20
Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock
FAP allogeneic immunosuppressive CAR-DC - Cardiogenic Shock, Cardiogenic Shock Post Myocardial Infarction
Phase 1Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine182026-01-202026-02-02
Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock
Cardiogenic Shock Acute, Bypass, Cardiopulmonary
RecruitingCentre Hospitalier Universitaire, Amiens25002025-10-202026-01-21
Prospective Validation of the STOPSHOCK Score - Artificial Intelligence Based Predictive Scoring System to Identify the Risk of Developing Cardiogenic Shock (CS) in Patients Suffering From Acute Coronary Syndrome (ACS)
Cardiogenic Shock, Cardiogenic Shock Acute
Enrolling by invitationPremedix Academy10462025-06-012025-07-29
Early Beta Blocker Administration in STEMI Patients With SCAI B Status
Metoprolol (MET), Plcacebo - ST Segment Elevation Myocardial Infarction (STEMI), Cardiogenic Shock Post Myocardial Infarction
Not applicableRecruitingTel-Aviv Sourasky Medical Center2002025-05-212025-05-28
Comparison of Central Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter and Central Venous Catheter
Mespere Venous Oximeter, Co-Oximeter - Sepsis, Post Cardiac Surgery Low Output Syndrome Requiring Inotropic/Vasopressor Therapy
UnknownMespere Lifesciences Inc.402014-10-012015-09-28

Narrower conditions

Shock, Cardiogenic (8)  ·  Myocardial Infarction (3)  ·  ST Elevation Myocardial Infarction (3)  ·  Acute Coronary Syndrome (1)  ·  Cardiovascular Diseases (1)  ·  Respiratory Insufficiency (1)  ·  Sepsis (1)  ·  Shock, Septic (1)

Broader conditions

Pathologic Processes (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Heart Diseases (9)  ·  Infarction (9)  ·  Ischemia (9)  ·  Myocardial Ischemia (9)  ·  Necrosis (9)  ·  Vascular Diseases (9)  ·  Cardiovascular Diseases (8)  ·  Shock (8)  ·  Myocardial Infarction (6)  ·  Infections (2)  ·  Inflammation (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Respiration Disorders (1)

Interventions

Ivabradine (1)  ·  Metoprolol (1)

Sponsors

Centre Hospitalier Universitaire, Amiens (1)  ·  Hospital de Santa Cruz, Portugal (1)  ·  Medical University of Vienna (1)  ·  Mespere Lifesciences Inc. (1)  ·  National Institute of Cardiovascular Diseases, Pakistan (1)  ·  Premedix Academy (1)  ·  Prince of Wales Hospital, Shatin, Hong Kong (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  University Hospital of Cologne (1)

Countries

Austria (1)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Israel (1)  ·  Pakistan (1)  ·  Portugal (1)  ·  Slovakia (1)

Top investigators

Abdul Hakeem, MD FACC, FSCAI, FASE (1)  ·  Asim Ali, MBBS (1)  ·  Michael Sharpe, MD, FRCPC (1)  ·  Xinyang Hu, PhD (1)  ·  Yishay Szekely, MD (1)

Results publications

PMID 24694530, PMID 27050189, PMID 37622654